Viral infections have afflicted human health and despite great advancements in scientific
knowledge and technologies, continue to affect our society today. The current coronavirus …

There is growing evidence that mesenchymal stem cell-derived extracellular vesicles and
exosomes can significantly improve the curative effect of oxidative stress-related diseases …

Acute respiratory distress syndrome (ARDS) continues to be a life-threatening challenge,
especially for patients in intensive care units (ICUs). Despite extensive research, cost …

Mesenchymal stem cell-derived small extracellular vesicles (MSC-EVs) are promising
nanotherapeutic agent for pneumonia (bacterial origin, COVID-19), but the optimal …

Acute lung injury (ALI) is associated with excessive inflammatory response, leading to acute
respiratory distress syndrome (ARDS) without timely treatment. A fewer effective drugs are …

Nanotechnology profoundly affects the advancement of medicine. Limitations in diagnosing
and treating cancer and chronic diseases promote the growth of nanomedicine. However …

Acute Respiratory Distress Syndrome (ARDS) is a clinically severe respiratory disease that
causes severe medical and economic burden. To improve therapeutic efficacy, effectively …

Nanotechnology‐based approaches are promising for the treatment of musculoskeletal
(MSK) disorders, which present significant clinical burdens and challenges, but their clinical …

The therapeutics based on nanoparticles (NPs) are considered as the promising strategy for
tumor detection and treatment. However, one of the most challenges is the adsorption of …

Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS),
induce high morbidity and mortality rates, which challenge the present approaches for the …